BioCity are delighted to announce that we are the headine sponsor for Medilink East Midland's (EM) flagship annual event, Innovation Day. Medilink EM Innovation Day 2020 will take place on 2 July at the Nottingham Belfry (NG8 6PY) from 9 am to 5 pm. This is...
WILTON – Worn Again has advanced industry efforts to replace the use of virgin materials in textiles with the commissioning of its first pilot-scale facility that can separate, decontaminate and then extract polyester (PET) and cellulose from mixed fabric waste. The step up from the laboratory...
On Friday, 31 January 2020 the United Kingdom formally left the European Union (EU), but what does this mean for your Intellectual Property (IP) rights? Patent protection will be unaffected by Brexit as there is currently no European Union system for protecting patents and the United...
BioAscent has been shortlisted in the Business Leadership and the Rising Stars categories at this year’s Scottish Life Sciences Awards. The Business Leadership Award recognises a management team that has significantly advanced its business. BioAscent’s management team has transformed the business bringing in chemistry and biology...
BioCity based Scientific Laboratory Supplies (SLS) has been named best supplier in the ‘Best Cost Saving Initiative’ category at the prestigious ‘Excellent Supplier and Contractor Event 2019’ held by Newcastle University. Only seven awards are made in a variety of categories and no other laboratory...
Cresset, innovative provider of computational software and services for small molecule drug discovery and design is joining the 3D-NEONET consortium of academics and SMEs. The consortium, which is funded through the EU’s Horizon 2020 program, was created to enhance the sharing of technologies and the...
Medilink UK, the largest representative body for the Health Technology sector in the UK, has appointed Mr Kevin Kiely as its CEO. Kevin was co-founder of the Medilink model over twenty five years ago, which for the first time brought together in a formal regional association,...
Pictured L-R: Dr Sharon Cheetham, Director and Dr Wioletta Pijacka, Study Director Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka. Wioletta is an in vivo...
Today Charnwood Molecular announce that Synova Capital has completed a significant investment. The deal will provide Charnwood with additional investment to support its continued development and growth. Synova will support Charnwood to deliver an ambitious growth plan, built upon increasing investment in the Business’s core capabilities...
Scottish Business Insider’s tech columnist Michael Feeley picks a diverse crop of firms with serious growth potential Novosound Established in 2018 by Dave Hughes, CTO, and Richard Cooper, CEO, as a spin-out from the University of the West of Scotland, Novosound’s patented technology eliminates limitations associated with...